237 related articles for article (PubMed ID: 34095338)
1. Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients.
Antar AAR; Yu T; Pisanic N; Azamfirei R; Tornheim JA; Brown DM; Kruczynski K; Hardick JP; Sewell T; Jang M; Church T; Walch SN; Reuland C; Bachu VS; Littlefield K; Park HS; Ursin RL; Ganesan A; Kusemiju O; Barnaba B; Charles C; Prizzi M; Johnstone JR; Payton C; Dai W; Fuchs J; Massaccesi G; Armstrong DT; Townsend JL; Keller SC; Demko ZO; Hu C; Wang MC; Sauer LM; Mostafa HH; Keruly JC; Mehta SH; Klein SL; Cox AL; Pekosz A; Heaney CD; Thomas DL; Blair PW; Manabe YC
Open Forum Infect Dis; 2021 Jun; 8(6):ofab195. PubMed ID: 34095338
[TBL] [Abstract][Full Text] [Related]
2. Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients.
Antar AAR; Yu T; Pisanic N; Azamfirei R; Tornheim JA; Brown DM; Kruczynski K; Hardick JP; Sewell T; Jang M; Church T; Walch SN; Reuland C; Bachu VS; Littlefield K; Park HS; Ursin RL; Ganesan A; Kusemiju O; Barnaba B; Charles C; Prizzi M; Johnstone JR; Payton C; Dai W; Fuchs J; Massaccesi G; Armstrong DT; Townsend JL; Keller SC; Demko ZO; Hu C; Wang MC; Sauer LM; Mostafa HH; Keruly JC; Mehta SH; Klein SL; Cox AL; Pekosz A; Heaney CD; Thomas DL; Blair PW; Manabe YC
medRxiv; 2021 Mar; ():. PubMed ID: 33688688
[TBL] [Abstract][Full Text] [Related]
3. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
Mollan KR; Eron JJ; Krajewski TJ; Painter W; Duke ER; Morse CG; Goecker EA; Premkumar L; Wolfe CR; Szewczyk LJ; Alabanza PL; Loftis AJ; Degli-Angeli EJ; Brown AJ; Dragavon JA; Won JJ; Keys J; Hudgens MG; Fang L; Wohl DA; Cohen MS; Baric RS; Coombs RW; Sheahan TP; Fischer WA
Clin Infect Dis; 2022 Aug; 75(1):e1028-e1036. PubMed ID: 35022711
[TBL] [Abstract][Full Text] [Related]
4. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.
Antar AAR; Yu T; Demko ZO; Hu C; Tornheim JA; Blair PW; Thomas DL; Manabe YC
Front Immunol; 2023; 14():1147549. PubMed ID: 37187756
[TBL] [Abstract][Full Text] [Related]
5. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
6. Self-Collected Oral Fluid Saliva Is Insensitive Compared With Nasal-Oropharyngeal Swabs in the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Outpatients.
Manabe YC; Reuland C; Yu T; Azamfirei R; Hardick JP; Church T; Brown DM; Sewell TT; Antar A; Blair PW; Heaney CD; Pekosz A; Thomas DL;
Open Forum Infect Dis; 2021 Feb; 8(2):ofaa648. PubMed ID: 33604399
[TBL] [Abstract][Full Text] [Related]
7. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
[TBL] [Abstract][Full Text] [Related]
8. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data.
Mallett S; Allen AJ; Graziadio S; Taylor SA; Sakai NS; Green K; Suklan J; Hyde C; Shinkins B; Zhelev Z; Peters J; Turner PJ; Roberts NW; di Ruffano LF; Wolff R; Whiting P; Winter A; Bhatnagar G; Nicholson BD; Halligan S
BMC Med; 2020 Nov; 18(1):346. PubMed ID: 33143712
[TBL] [Abstract][Full Text] [Related]
9. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
[TBL] [Abstract][Full Text] [Related]
10. Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis.
Bardossy AC; Korhonen L; Schatzman S; Gable P; Herzig C; Brown NE; Beshearse E; Varela K; Sabour S; Lyons AK; Overton R; Hudson M; Hernandez-Romieu AC; Alvarez J; Roman K; Weng M; Soda E; Patel PR; Grate C; Dalrymple LS; Wingard RL; Thornburg NJ; Halpin ASL; Folster JM; Tobin-D'Angelo M; Lea J; Apata I; McDonald LC; Brown AC; Kutty PK; Novosad S
Kidney360; 2021 Dec; 2(12):1917-1927. PubMed ID: 35419540
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Less Invasive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Diagnostic Specimens in Nursing Home Residents-Arkansas, June-August 2020.
Gable P; Huang JY; Gilbert SE; Bollinger S; Lyons AK; Sabour S; Surie D; Biedron C; Haney T; Beshearse E; Gregory CJ; Seely KA; Clemmons NS; Patil N; Kothari A; Gulley T; Garner K; Anderson K; Thornburg NJ; Halpin AL; McDonald LC; Kutty PK; Brown AC;
Clin Infect Dis; 2021 Jul; 73(Suppl 1):S58-S64. PubMed ID: 33909063
[TBL] [Abstract][Full Text] [Related]
12. Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates.
Mollan KR; Eron JJ; Krajewski TJ; Painter W; Duke ER; Morse CG; Goecker EA; Premkumar L; Wolfe CR; Szewczyk LJ; Alabanza PL; Loftis AJ; Degli-Angeli EJ; Brown AJ; Dragavon JA; Won JJ; Keys J; Hudgens MG; Fang L; Wohl DA; Cohen MS; Baric RS; Coombs RW; Sheahan TP; Fischer WA
medRxiv; 2021 Jun; ():. PubMed ID: 34100024
[TBL] [Abstract][Full Text] [Related]
13. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY
Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Antigen Results Correlate with the Quantity of Replication-Competent SARS-CoV-2 in a Cross-Sectional Study of Ambulatory Adults during the Delta Wave.
Tu YP; Green C; Hao L; Greninger AL; Morton JF; Sights HA; Gale M; Drain PK
Microbiol Spectr; 2023 Jun; 11(3):e0006423. PubMed ID: 37097146
[TBL] [Abstract][Full Text] [Related]
15. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study.
Fox-Lewis A; Fox-Lewis S; Beaumont J; Drinković D; Harrower J; Howe K; Jackson C; Rahnama F; Shilton B; Qiao H; Smith KK; Morpeth SC; Taylor S; Blakiston M; Roberts S; McAuliffe G
Pathology; 2021 Jun; 53(4):530-535. PubMed ID: 33838922
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
medRxiv; 2021 Dec; ():. PubMed ID: 34909794
[TBL] [Abstract][Full Text] [Related]
18. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L
Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376
[TBL] [Abstract][Full Text] [Related]
20. Association of Nirmatrelvir/Ritonavir Treatment on Upper Respiratory Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription-Polymerase Chain Reaction (SARS-Cov-2 RT-PCR) Negative Conversion Rates Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19).
Li H; Gao M; You H; Zhang P; Pan Y; Li N; Qin L; Wang H; Li D; Li Y; Qiao H; Gu L; Xu S; Guo W; Wang N; Liu C; Gao P; Niu J; Cao J; Zheng Y
Clin Infect Dis; 2023 Feb; 76(3):e148-e154. PubMed ID: 35870128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
